NIH-funded research R21 grant

Understanding how metabolic changes affect prostate cancer in African American men

Official title: Identification of metabolic adducts associated with prostate cancer progression in African American men

Funded at Beckman Research Institute/city of Hope · NIH-10721809 · Data updated 2026-11-12

This study is looking at why African American men have higher rates of prostate cancer by examining certain changes in their bodies that might lead to the disease, and it hopes to use this information to create better tests and treatments for prostate cancer, with the help of patients who can provide samples.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBeckman Research Institute/city of Hope
NIH-funded
Lab location1 site (Duarte, United States)
Project startSeptember 22, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$466,478
NIH project number1R21CA282612-01
Project IDNIH-10721809 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are African American men who are at risk for or diagnosed with prostate cancer.

Less likely to help

Patients who are not African American or those without a diagnosis of prostate cancer may not benefit from this research.

What this research studies

This research investigates the biological changes that contribute to the higher rates of prostate cancer in African American men. It focuses on identifying specific metabolic adducts, particularly those formed by a compound called methylglyoxal, which may lead to DNA mutations and cancer progression. By analyzing these metabolic changes, the study aims to develop better diagnostic tests and personalized treatments for prostate cancer. Patients may be involved in providing biological samples to help identify these metabolic markers.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic and treatment options specifically tailored for African American men with prostate cancer.

How similar studies have gone: Previous research has indicated that metabolic changes play a significant role in cancer progression, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Beckman Research Institute/city of Hope
    Duarte, United States
    Active

Researchers

  • Principal investigator: Shuck, Sarah C. — Beckman Research Institute/city of Hope
  • Study coordinator: Shuck, Sarah C.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.